摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N2-(4-fluorophenyl)-4-methoxybenzene-1,2-diamine | 582310-30-3

中文名称
——
中文别名
——
英文名称
N2-(4-fluorophenyl)-4-methoxybenzene-1,2-diamine
英文别名
2-N-(4-fluorophenyl)-4-methoxybenzene-1,2-diamine
N2-(4-fluorophenyl)-4-methoxybenzene-1,2-diamine化学式
CAS
582310-30-3
化学式
C13H13FN2O
mdl
MFCD24977688
分子量
232.257
InChiKey
KTLYPJGQIALFRE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.076
  • 拓扑面积:
    47.3
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-噻吩甲醛N2-(4-fluorophenyl)-4-methoxybenzene-1,2-diamine 在 sodium hydrogen sulfite 作用下, 以 NaHSO3乙醇 为溶剂, 生成 6-Methoxy-1-(4-fluorophenyl)-2-(3-thienyl)-1H-benzimidazole
    参考文献:
    名称:
    1-Phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
    摘要:
    本文介绍了新的苯并咪唑衍生物,它们的制备方法以及它们用于生产用于治疗和预防与微神经胶质细胞活化和T细胞介导的免疫性疾病相关的药物,以及含有新的苯并咪唑衍生物的制药制剂。
    公开号:
    US20030229085A1
  • 作为产物:
    描述:
    (4-fluorophenyl)-(4-methoxyphenyl)diazene盐酸 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 2.5h, 以70.56%的产率得到N2-(4-fluorophenyl)-4-methoxybenzene-1,2-diamine
    参考文献:
    名称:
    在不同溶剂中辐照 4-甲氧基-4'-取代偶氮苯选择性合成 N-芳基苯-1,2-二胺或 1-芳基苯并咪唑。
    摘要:
    研究了 4-甲氧基偶氮苯的溶剂可控光反应得到 1-芳基-1H-苯并咪唑或 N-芳基苯-1,2-二胺。4-甲氧基偶氮苯在含有 0.5 M 盐酸的 DMF 中辐照产生 N 2-aryl-4-methoxybenzo-1,2-diamines 作为主要产物,而在含有 0.16 M 盐酸的乙缩醛中辐照产生 1-aryl-6-主要产品为甲氧基-2-甲基-1H-苯并咪唑。还讨论了解释选择性的可能反应机制。
    DOI:
    10.1039/d0ra10068d
点击查看最新优质反应信息

文献信息

  • 1-Phenyl-2-heteroaryl-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
    申请人:Blume Thorsten
    公开号:US20050267160A1
    公开(公告)日:2005-12-01
    New benzimidazole derivatives are described, their production and their use for the production of pharmaceutical agents for treatment and prevention of diseases that are associated with a microglia activation and T-cell-mediated immunological diseases, as well as pharmaceutical preparations that contain the new benzimidazole derivatives.
    本文描述了新的苯并咪唑衍生物,它们的生产以及它们用于制备与微胶质细胞激活和T细胞介导的免疫性疾病有关的药物治疗和预防疾病的用途,以及包含新的苯并咪唑衍生物的制药制剂。
  • 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
    申请人:Blume Thorsten
    公开号:US06962932B2
    公开(公告)日:2005-11-08
    New benzimidazole derivatives are described, their production and their use for the production of pharmaceutical agents for treatment and prevention of diseases that are associated with a microglia activation and T-cell-mediated immunological diseases, as well as pharmaceutical preparations that contain the new benzimidazole derivatives.
    本文描述了新的苯并咪唑衍生物,它们的生产以及它们用于生产用于治疗和预防与小胶质细胞激活和T细胞介导的免疫性疾病相关的药物制剂,以及含有新苯并咪唑衍生物的药物制剂。
  • 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
    申请人:Bayer Schering Pharma Aktiengesellschaft
    公开号:US07683081B2
    公开(公告)日:2010-03-23
    New benzimidazole derivatives are described, their production and their use for the production of pharmaceutical agents for treatment and prevention of diseases that are associated with a microglia activation and T-cell-mediated immunological diseases, as well as pharmaceutical preparations that contain the new benzimidazole derivatives.
    本文描述了新的苯并咪唑衍生物,它们的生产以及它们用于生产治疗与微胶质细胞活化和T细胞介导的免疫性疾病相关的药物制剂,以及包含新苯并咪唑衍生物的药物制剂。
  • The selective synthesis of <i>N</i>-arylbenzene-1,2-diamines or 1-arylbenzimidazoles by irradiating 4-methoxy-4′-substituted-azobenzenes in different solvents
    作者:Po-Yi Chen、Chi-Wei Hsu、Tong-Ing Ho、Jinn-Hsuan Ho
    DOI:10.1039/d0ra10068d
    日期:——
    The solvent-controllable photoreaction of 4-methoxyazobenzenes to afford 1-aryl-1H-benzimidazoles or N-arylbenzene-1,2-diamines has been studied. The irradiation of 4-methoxyazobenzenes in DMF containing 0.5 M hydrochloric acid provided N 2-aryl-4-methoxybenzene-1,2-diamines as the major product, while irradiation in acetal containing 0.16 M hydrochloric acid led to 1-aryl-6-methoxy-2-methyl-1H-benzimidazoles
    研究了 4-甲氧基偶氮苯的溶剂可控光反应得到 1-芳基-1H-苯并咪唑或 N-芳基苯-1,2-二胺。4-甲氧基偶氮苯在含有 0.5 M 盐酸的 DMF 中辐照产生 N 2-aryl-4-methoxybenzo-1,2-diamines 作为主要产物,而在含有 0.16 M 盐酸的乙缩醛中辐照产生 1-aryl-6-主要产品为甲氧基-2-甲基-1H-苯并咪唑。还讨论了解释选择性的可能反应机制。
  • 1-Phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
    申请人:Schering Aktiengesellschaft
    公开号:US20030229085A1
    公开(公告)日:2003-12-11
    New benzimidazole derivatives are described, their production and their use for the production of pharmaceutical agents for treatment and prevention of diseases that are associated with a microglia activation and T-cell-mediated immunological diseases, as well as pharmaceutical preparations that contain the new benzimidazole derivatives.
    本文介绍了新的苯并咪唑衍生物,它们的制备方法以及它们用于生产用于治疗和预防与微神经胶质细胞活化和T细胞介导的免疫性疾病相关的药物,以及含有新的苯并咪唑衍生物的制药制剂。
查看更多